Home/Filings/4/0000950170-24-051243
4//SEC Filing

Delaney William E IV 4

Accession 0000950170-24-051243

CIK 0001426800other

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 4:05 PM ET

Size

5.2 KB

Accession

0000950170-24-051243

Insider Transaction Report

Form 4
Period: 2024-04-29
Delaney William E IV
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2024-04-29+3,33316,109 total
Footnotes (2)
  • [F1]Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On April 29, 2024, a performance-based vesting condition was achieved.
  • [F2]Reflects equitable adjustment of the number of shares beneficially owned by the reporting person resulting from a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2023, which is exempt from reporting pursuant to Rule 16a-9.

Documents

1 file

Issuer

ASSEMBLY BIOSCIENCES, INC.

CIK 0001426800

Entity typeother

Related Parties

1
  • filerCIK 0001812734

Filing Metadata

Form type
4
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 4:05 PM ET
Size
5.2 KB